Italy
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
55.29%
|
Dec. 31, 2023 | USD 2.00 | 0.87% |
|
Italy |
|
2 |
34.01%
|
Dec. 31, 2023 | USD 61.94 | 0.17% |
|
Italy |
|
3 |
29.04%
|
Dec. 31, 2023 | USD 106.08 | -0.85% |
|
Italy |
|
4 |
26.26%
|
Dec. 31, 2023 | USD 54.52 | 1.77% |
|
Italy |
|
5 |
25.09%
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
6 |
15.68%
|
Dec. 31, 2023 | USD 9.87 | -1.00% |
|
Italy |
|
7 |
-8.85%
|
Dec. 31, 2023 | USD 19.11 | -0.17% |
|
Italy |
|
8 |
-129.40%
|
Dec. 31, 2023 | USD 10.99 | 1.17% |
|
Italy |
The Healthcare company in Italy with the highest EBITDA Margin is Arterra Bioscience (Milan Stock Exchange: ARBS.MI) at 55.29%.
The Healthcare company in Italy with the lowest EBITDA Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -129.40%.
The top 10 Healthcare companies in Italy by EBITDA Margin are Arterra Bioscience, Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., Pharmanutra S.p.A., Stevanato Group S.p.A., GPI S.p.A., Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Healthcare companies in Italy by EBITDA Margin are Newron Pharmaceuticals S.p.A., Philogen S.p.A., GPI S.p.A., Stevanato Group S.p.A., Pharmanutra S.p.A., DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and Arterra Bioscience.